Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 29, 2009
[DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma]Xian-ming Liu, Hua-qing Wang, Hui-lai Zhang, et al.
Zhonghua Yi Xue Za Zhi|August 6, 2003
[Treatment of malignant lymphoma by autologous hematopoietic stem cell transplantation combined with high dose radiotherapy and chemotherapy]Hua-qing Wang, Xiu-zhen Cui, Xiu-bao Ren, et al.
Thoracic Cancer|September 19, 2017
Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancerHua-Qing Wang, Yangang Ren, Zheng-Zi Qian, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 11, 2021
[Clinical Significance of EBV-DNA Copy Number in EBV Positive Lymphoma Patients]Li-Hua Qiu, Yue-Yang Li, Ya-Xin Zheng, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|February 21, 2012
[Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma]Yun Hou, Hua-qing Wang, Kai Fu, et al.
Oncotarget|September 17, 2017
Necroptosis as a potential therapeutic target in multiple organ dysfunction syndromeYao-Li Cui, Li-Hua Qiu, Shi-Yong Zhou, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 9, 2012
Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumorsXian-Huo Wang, Shi-Yong Zhou, Zheng-Zi Qian, et al.
Chinese Medical Journal|December 18, 2010
Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancerHua-Qing Wang, Zheng-Zi Qian, Xian-Ming Liu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 12, 2012
[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma]Yun Hou, Hua-qing Wang, Kai Fu, et al.
Annals of Hematology|July 31, 2021
Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 studyXiao-Xiao Wang, Yan Gao, Jie Jin, et al.
Pageof 4